Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 570-572

  Spanaki, A ^a   Linardakis, E ^a   Perdikogianni, C ^a   Stiakaki, E ^a   Morotti, A ^b   Cilloni, D ^b   Kalmanti, M ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute leukemia; Children; Molecular markers; RQ PCR (real time quantitative RT PCR); WT1

Indexed keywords

WT1 PROTEIN;

ACUTE LEUKEMIA; ADOLESCENT; BONE MARROW; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SOLID TUMOR;

ADOLESCENT; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; WT1 PROTEINS;

EID: 33846676983     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.030     Document Type: Letter

References (13)

1. Scharnhorst V., Van der Eb A.J., and Jochemsen A.G. WT1 proteins: functions in growth and differentiation. Gene 273 (2001) 141-161
2. Yanada M., Terakura S., Yokozawa T., Yamamoto K., Kiyoi H., Emi N., et al. Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukaemia. Leukemia Lymph 45 (2004) 1803-1808
3. Ostergaard M., Olesen L.H., Hasle H., Kjeldsen E., and Hokland P. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients-results from a single-centre study. Br J Haematol 125 (2004) 590-600
4. Barragan E., Cervera J., Bolufer P., Ballester S., Martin G., Fernandez P., et al. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 89 (2004) 926-933
5. Na I.K., Kreuzer K.A., Lupberger J., Dorken B., and Coutre P. Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl+CML. Leukemia Res 29 (2005) 343-345
6. Tamaki H., Ogawa H., Ohyashiki K., Ohyashiki J.H., Iwama H., Inoue K., et al. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 13 (2000) 393-399
7. Patmasiriwat P., Fraizer G., Kantarjian H., and Saunders G.F. WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia. Leukemia 13 (1999) 891-900
8. Van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukaemia. Leukemia 13 (1999) 1901-1928
9. Cilloni D., Gottardi E., De Micheli D., Serra A., Volpe G., Messa F., et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukaemia patients. Leukemia 16 (2002) 2115-2121
10. Beillard E., Pallisgaard N., Van der Velden V.H., Bi W., Dee R., van der Schoot E., et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using real time quantitative RT-PCR-a Europe against cancer program. Leukemia 17 (2003) 2474-2486
11. Rosenfeld C., Cheever M.A., and Gaiger A. WT1 in acute leukaemia, chronic myelogenous leukemias and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 17 (2003) 1301-1312
12. Elmaagacli A., Koldehoff M., Peceny R., Klein-Hitpass L., Ottinger H., Beelen D.W., et al. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 90 (2005) 326-334
13. Cilloni D., and Saglio G. WT1 as a universal maker for MRD detection and quantification in myeloid leukemias and in MDS. Acta Haematol 112 (2004) 79-84